Speaking over the HMPV virus cases, the Chairman of PSRI Institute of Pulmonary, Critical Care & Sleep Medicine, Dr Gopi Chand Khilnani said the situation this time is not similar to situation that we ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

Share on Pinterest PongMoji/Getty Images Spirometry is an important tool for diagnosing and determining treatment for chronic obstructive pulmonary disease (COPD). This breathing test can detect ...

Conclusion. In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease treatment failure rates, decrease the risk of relapse, and may improve symptoms ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...